KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Debt Ratio (2016 - 2025)

Pacira BioSciences has reported Debt Ratio over the past 14 years, most recently at 0.29 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.29 for Q4 2025, down 21.91% from a year ago — trailing twelve months through Dec 2025 was 0.29 (down 21.91% YoY), and the annual figure for FY2025 was 0.29, down 21.91%.
  • Debt Ratio for Q4 2025 was 0.29 at Pacira BioSciences, up from 0.29 in the prior quarter.
  • Over the last five years, Debt Ratio for PCRX hit a ceiling of 0.38 in Q4 2024 and a floor of 0.07 in Q2 2024.
  • Median Debt Ratio over the past 5 years was 0.17 (2022), compared with a mean of 0.18.
  • Biggest five-year swings in Debt Ratio: plummeted 62.16% in 2023 and later skyrocketed 378.98% in 2024.
  • Pacira BioSciences' Debt Ratio stood at 0.33 in 2021, then crashed by 48.75% to 0.17 in 2022, then crashed by 53.55% to 0.08 in 2023, then skyrocketed by 378.98% to 0.38 in 2024, then fell by 21.91% to 0.29 in 2025.
  • The last three reported values for Debt Ratio were 0.29 (Q4 2025), 0.29 (Q3 2025), and 0.2 (Q2 2025) per Business Quant data.